NovaBay Pharmaceuticals Inc (NBY)
0.0804
0.00 (0.00%)
USD |
NYAM |
Apr 26, 15:28
NovaBay Pharmaceuticals Total Assets (Quarterly): 9.034M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 9.034M |
September 30, 2023 | 12.85M |
June 30, 2023 | 16.01M |
March 31, 2023 | 14.82M |
December 31, 2022 | 16.40M |
September 30, 2022 | 22.38M |
June 30, 2022 | 21.54M |
March 31, 2022 | 24.79M |
December 31, 2021 | 23.98M |
September 30, 2021 | 12.24M |
June 30, 2021 | 13.60M |
March 31, 2021 | 14.07M |
December 31, 2020 | 15.24M |
September 30, 2020 | 17.08M |
June 30, 2020 | 13.27M |
March 31, 2020 | 9.475M |
December 31, 2019 | 11.22M |
September 30, 2019 | 14.60M |
June 30, 2019 | 9.87M |
March 31, 2019 | 9.72M |
December 31, 2018 | 9.361M |
September 30, 2018 | 10.36M |
June 30, 2018 | 11.70M |
March 31, 2018 | 13.82M |
December 31, 2017 | 10.08M |
Date | Value |
---|---|
September 30, 2017 | 11.06M |
June 30, 2017 | 12.07M |
March 31, 2017 | 12.68M |
December 31, 2016 | 15.38M |
September 30, 2016 | 15.14M |
June 30, 2016 | 7.005M |
March 31, 2016 | 4.931M |
December 31, 2015 | 5.077M |
September 30, 2015 | 6.69M |
June 30, 2015 | 10.17M |
March 31, 2015 | 8.155M |
December 31, 2014 | 7.537M |
September 30, 2014 | 11.04M |
June 30, 2014 | 13.51M |
March 31, 2014 | 17.18M |
December 31, 2013 | 15.65M |
September 30, 2013 | 12.24M |
June 30, 2013 | 12.83M |
March 31, 2013 | 15.42M |
December 31, 2012 | 19.24M |
September 30, 2012 | 13.67M |
June 30, 2012 | 12.07M |
March 31, 2012 | 14.04M |
December 31, 2011 | 15.96M |
September 30, 2011 | 18.30M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
9.034M
Minimum
Dec 2023
24.79M
Maximum
Mar 2022
15.39M
Average
14.60M
Median
Sep 2019
Total Assets (Quarterly) Benchmarks
Eyenovia Inc | 28.78M |
Palatin Technologies Inc | 13.55M |
iBio Inc | 34.02M |
Theriva Biologics Inc | 55.22M |
Oragenics Inc | 4.966M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 5.72M |
Shareholders Equity (Quarterly) | 3.314M |
Debt to Equity Ratio | 0.3431 |
Current Ratio | 1.672 |
Net Debt Paydown Yield | -9.93% |